Evidence map›Paper›PMID 39687094›Full record

ArticleHeliyon2024

An automatic approach to detect skin cancer utilizing active infrared thermography.

Ricardo F Soto, Sebastián E Godoy

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ricardo F SotoDepartment of Electrical Engineering, Universidad de Concepción, Edmundo Larenas 219, Concepción, 4030000, Biobío, Chile.
Sebastián E GodoyDepartment of Electrical Engineering, Universidad de Concepción, Edmundo Larenas 219, Concepción, 4030000, Biobío, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin cancer is a growing global concern, with cases steadily rising. Typically, malignant moles are identified through visual inspection, using dermatoscopy and patient history. Active thermography has emerged as an effective method to distinguish between malignant and benign lesions. Our previous research showed that spatio-temporal features can be extracted from suspicious lesions to accurately determine malignancy, which was applied in a distance-based classifier. In this study, we build on that foundation by introducing a set of novel spatial and temporal features that enhance classification accuracy and can be integrated into any machine learning approach. These features were implemented in a support-vector machine classifier to detect malignancy. Notably, our method addresses a common limitation in existing approaches-manual lesion selection-by automating the process using a U-Net convolutional neural network. We validated our system by comparing U-Net's performance with expert dermatologist segmentations, achieving a 17% improvement in the Jaccard index over a semi-automatic algorithm. The detection algorithm relies on accurate lesion segmentation, and its performance was evaluated across four segmentation techniques. At an 85% sensitivity threshold, expert segmentation provided the highest specificity at 87.62%, while non-expert and U-Net segmentations achieved comparable results of 69.63% and 68.80%, respectively. Semi-automatic segmentation lagged behind at 64.45%. This automated detection system performs comparably to high-accuracy methods while offering a more standardized and efficient solution. The proposed automatic system achieves 3% higher accuracy compared to the ResNet152V2 network when processing low-quality images obtained in a clinical setting.

Indexed as

Convolutional neural networksDynamic thermal imagingImage segmentationMachine learningSkin cancer screening

Identifiers

PMID39687094
PMCPMC11647852

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.